Related Experiment Video
Updated: Sep 21, 2025

14:10
Characterizing Salmonella Typhimurium-induced Septic Peritonitis in Mice
Published on: July 29, 2022
5.5K
Analysis of Salmonella Typhi Pathogenesis in a Humanized Mouse Model
Taylor A Stepien1, Stephen J Libby2, Joyce E Karlinsey3
1Department of Global Health, University of Washington, Seattle, WA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|May 26, 2022
Summary
A humanized mouse model using CD34+ stem cells allows researchers to study Salmonella Typhi pathogenesis. This model successfully recapitulates human typhoid fever, aiding in the identification of bacterial virulence factors.
Area of Science:
- Infectious Diseases
- Immunology
- Microbiology
Background:
- Salmonella enterica serovar Typhi causes typhoid fever but lacks a suitable animal model for pathogenesis studies.
- Previous research efforts were hindered by the absence of tractable models to investigate human-restricted pathogens.
Purpose of the Study:
- To develop and validate a humanized mouse model for studying Salmonella Typhi pathogenesis.
- To enable the investigation of molecular mechanisms of typhoid fever in a relevant in vivo system.
Main Methods:
- Utilized genetically modified mice engrafted with human CD34+ stem cells (CD34+ Hu-NSG mice).
- Infected CD34+ Hu-NSG mice with Salmonella Typhi.
- Constructed and analyzed a transposon-directed insertion site sequencing library for S. Typhi.
Main Results:
- CD34+ Hu-NSG mice developed lethal systemic Salmonella Typhi infections dependent on human hematopoietic cells.
- The model recapitulated key immunological and pathological features of human typhoid fever.
- The model facilitated the identification of bacterial genetic determinants of S. Typhi virulence.
Conclusions:
- The CD34+ humanized mouse model is a valuable tool for studying human-restricted pathogens like Salmonella Typhi.
- This model overcomes limitations of previous animal models, enabling deeper understanding of typhoid fever.
- It supports the discovery of bacterial virulence factors and potential therapeutic targets.

